Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
about
Phyto-oestrogens and breast cancer chemopreventionRoles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer MetastasisResveratrol and MyopathyProperties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and HumansThe human paraoxonase gene cluster as a target in the treatment of atherosclerosisNuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease preventionResveratrol modulates the inflammatory response via an estrogen receptor-signal integration networkInfluence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer preventionPhytoestrogens and breast cancer prevention: possible mechanisms of actionTrans-resveratrol inhibits phosphorylation of Smad2/3 and represses FSHβ gene expression by a SirT1-independent pathway in LβT2 gonadotrope cells.Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylationResveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells.New steroidal aromatase inhibitors: suppression of estrogen-dependent breast cancer cell proliferation and induction of cell death.Determination of Flavonoids and Resveratrol in Wine by Turbulent-Flow Chromatography-LC-MSSex Differences in the Effect of Resveratrol on DSS-Induced Colitis in Mice.Resveratrol and cancer: focus on in vivo evidence.Network pharmacology-based and clinically relevant prediction of the active ingredients and potential targets of Chinese herbs in metastatic breast cancer patients.Plum and soy aglycon extracts superior at increasing bone calcium retention in ovariectomized Sprague Dawley ratsFemale reproductive disorders: the roles of endocrine-disrupting compounds and developmental timingResveratrol derivatives as promising chemopreventive agents with improved potency and selectivity.Resveratrol, a red wine constituent, blocks the antimitogenic effects of estradiol on human female coronary artery smooth muscle cells.Resveratrol promotes expression of SIRT1 and StAR in rat ovarian granulosa cells: an implicative role of SIRT1 in the ovary.Potential of resveratrol analogues as antagonists of osteoclasts and promoters of osteoblasts.Estrogen receptor expression is required for low-dose resveratrol-mediated repression of aryl hydrocarbon receptor activity.Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axisDifferential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.Evidence of ERalpha and ERbeta selectivity and partial estrogen agonism in traditional Chinese medicine.Resveratrol and endometrium: a closer look at an active ingredient of red wine using in vivo and in vitro models.Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells.Resveratrol neuroprotection in stroke and traumatic CNS injury.Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathwayDietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice.Differential induction of quinone reductase by phytoestrogens and protection against oestrogen-induced DNA damageA pilot clinical study of resveratrol in postmenopausal women with high body mass index: effects on systemic sex steroid hormones.Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth.Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells.Acetylation and nuclear receptor actionAcetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor.Resveratrol derivatives: a patent review (2009 - 2012).Genistein stimulates MCF-7 breast cancer cell growth by inducing acid ceramidase (ASAH1) gene expression.
P2860
Q24794947-B11D0CE4-EF7E-4040-A941-C8D188F6AC75Q26745561-67E8B595-2DA6-463D-A2A9-7C632B0798FFQ26748160-6D519AC4-56B4-49E6-978C-BAF40E0F621BQ26801926-B333BD21-DD1E-4985-A0C1-58401B587730Q26824356-5AA814C3-4C41-4E23-B21A-DB0885C987B2Q26849574-6284D0DF-D565-40AC-970B-4C23D68D51E5Q27683572-D01E26F8-B3ED-4018-B4E9-4CC9F3BB387AQ28258801-39068135-2974-461D-A88C-906E3A29A7E6Q28276620-6E1578F7-C18A-46C7-8A26-0B4E7534107DQ30426256-97236A16-6A57-4B7A-A2D0-8CCC022FBAD8Q31060276-DFE63FE8-B036-44D3-9A1D-81532C142187Q33260568-58FA7088-A664-4FBC-978C-BCC2A7845FC1Q33354763-0F4FCAEA-ADEB-44E1-B65A-AAB85CC2FCB0Q33442922-81FCE7C8-8670-4F88-B577-FE5FD2678757Q33561060-AC83A005-5610-4F58-AB8B-2775DB64BE76Q33578943-E007C79E-411E-4735-9065-F001350EC5EDQ33688907-F1FC7FFC-ABD5-4013-9F93-921916B80893Q33847745-E769DA6E-CD1E-4385-95E6-3E032DD4B2D6Q33862059-E3340154-EA71-416D-942F-E7AF47D33ACEQ34054119-0EE81100-9234-480B-9239-28E35E6607B8Q34113185-FB7FF6B3-05FB-4B8C-B6FF-220212E6849CQ34167144-20031F2F-1715-496C-BC8E-CC5B14D3E4D1Q34242787-2C6C6366-49DA-42D2-8168-5C440578E110Q34257548-32613A69-C614-4A92-8C6D-8925073192B6Q34316229-9C96DD68-2EE3-4C61-B30C-3766697D2A48Q34332592-C9EB43CA-0D7D-4364-8A48-CA9DD03B1FDCQ34363082-3325A1E8-B89F-4C78-8497-EC3D9AA0BBB7Q34418007-B498E805-4239-4D17-A5F4-FFD8535EB76EQ34445175-C691517B-8C75-4903-87DE-E9414E10D504Q34489690-00207D26-FC48-4729-8173-0A29CA172651Q34525461-D6CDAAED-DF72-423E-8998-13861557E7C4Q34539310-B8D0C3E1-F9A1-4305-8C9D-F2F253593915Q34551489-C2DD6D85-0388-42D6-BB1D-126F13DF7DFFQ34570111-8315C434-BC87-45F7-8CF8-F08E2666171AQ34571083-8B1E4162-F558-4020-B95C-B9D7EBA438EBQ34651821-3DB3B6C5-6601-4566-AFC8-AB84B311C024Q34666075-31D49C8F-C2C0-4519-9035-B9ADFB76D862Q34698474-66A9D89E-9A80-4F76-A837-97CD5027E110Q34986494-D8315E4B-5527-4200-A561-05BC26C0436AQ35010927-DE493356-55CE-4FF5-B497-7A8FB2A4E717
P2860
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
@ast
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
@en
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
@nl
type
label
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
@ast
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
@en
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
@nl
prefLabel
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
@ast
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
@en
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
@nl
P2093
P356
P1433
P1476
Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
@en
P2093
C M Klinge
J L Bowers
S C Jernigan
V V Tyulmenkov
P304
P356
10.1210/ENDO.141.10.7721
P407
P577
2000-10-01T00:00:00Z